Aspermont Limited | Finanzwire

Basculer en Français

8295	Companies
114833	Keywords
55274	Articles
62430	Press releases

Home
Companies
Aspermont Limited

BRIEF

published on 10/24/2024 at 10:36, 28 days ago

Aspermont Ltd. Sees Revenue Growth in H2 2024

Revenue Growth Digital Media Aspermont Ltd. Subscription Model Cash Reserves
PRESS RELEASE

published on 10/24/2024 at 10:31, 28 days ago

Original-Research: Aspermont Ltd. (von GBC AG): Buy
Aspermont Ltd.'s H2 2024 results show revenue growth, profitability, and managed cash reserves. Transition to digital model and focus on subscriptions set stage for substantial growth

Digital Transformation Revenue Growth Aspermont Ltd. Subscriptions H2 2024 Results
BRIEF

published on 10/04/2024 at 10:06, 1 month 17 days ago

Aspermont Ltd. Sees Growth After Challenging First Half of 2024

BUY Rating Aspermont Ltd. Q3 2024 Growth Strategic Recruitment Revenue Quality
PRESS RELEASE

published on 10/04/2024 at 10:01, 1 month 17 days ago

Original-Research: Aspermont Ltd. (von GBC AG): Buy
Aspermont Ltd. shows growth potential post-challenging H1 2024 with strong cash position and revenue increase. Analysts recommend buying with revised target price

Revenue Increase Cash Position BUY Rating Growth Potential Aspermont Ltd.
BRIEF

published on 03/12/2024 at 12:06, 8 months 8 days ago

Aspermont Ltd. Garners "Buy" Rating from GBC AG with Adjusted Target Price

BUY Rating Target Price Adjustment Double-digit Growth Aspermont Ltd Strategic Hiring
PRESS RELEASE

published on 03/12/2024 at 12:01, 8 months 8 days ago

Original-Research: Aspermont Ltd. (von GBC AG): Buy
GBC AG releases research report on Aspermont Ltd., recommending a buy with a target price of 0.07 AUD by 31.12.2024. Company shows continued growth and capital efficiency

Buy Recommendation GBC AG Research Report Aspermont Ltd. Capital Efficiency
PRESS RELEASE

published on 08/28/2023 at 12:02, 1 year 2 months ago

Original-Research: Aspermont Ltd (von GBC AG): Buy
PRESS RELEASE

published on 06/22/2023 at 10:02, 1 year 4 months ago

Original-Research: Aspermont Ltd (von GBC AG): Buy
PRESS RELEASE

published on 05/22/2023 at 11:01, 1 year 5 months ago

Original-Research: Aspermont Ltd (von GBC AG): Buy
PRESS RELEASE

published on 02/24/2023 at 12:01, 1 year 8 months ago

Original-Research: Aspermont Ltd (von GBC AG): Buy

Accesswire

Published on 11/21/2024 at 10:03, 40 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 43 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 43 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 10 hours 8 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 18 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 10:30, 13 minutes ago

MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024
Published on 11/21/2024 at 10:04, 38 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 41 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 43 minutes ago

Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 43 minutes ago

Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV

Les Echos

Published on 11/21/2024 at 06:58, 3 hours 45 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 23 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 16 hours 58 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 16 hours 58 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 2 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE